SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.07-3.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (28441)3/2/1999 9:19:00 AM
From: Mudcat  Read Replies (2) of 32384
 
<Breast cancer will be treated with combination treatments>

I agree, but I also think the combination selected will be based on which one works the best. If the AHP drug turns out to be better than Targretin then that is the one that will be used in the combination. Seems like there will be alot of competition in the breast cancer treatment area. I'm only pointing out that I hope that Lgnd doesn't help the competition so much that they come up with something better and hurt Lgnd in the long run.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext